There is a persistent belief in clinical development that Phase I studies are impossible or prohibited in Serbia. Recent discussions with local experts paint a very different picture.

Being a Principal Investigator (PI) may seem complex, but it is entirely achievable with the right qualifications and guidance.

Check out the Hungary guide and see how you could become a Principal Investigator

Following our previous insights on feasibility and site performance, one important aspect is often overlooked: The broader value these studies bring — beyond the protocol. Based on our experience at Viacrystal, particularly in studies involving established or generic treatments in schizophrenia, several consistent patterns emerged across Hungary, Serbia, and Croatia. 1. Strong regulatory support Regulatory authorities in the region are generally supportive of these studie

Why Schizophrenia Feasibility Is Uniquely Challenging Unlike many somatic indications, schizophrenia trials involve layers of complexity that are often underestimated: Variability in diagnosis and symptom stability Dependence on caregiver and family support High screen failure rates due to strict inclusion criteria Fluctuating patient compliance and retention risks Site-level differences in patient management practices This makes surface-level feasibility dangerously m

Celebrating 5 years in Viacrystal Budapest Headquarters

As the CEO of a small-sized Contract Research Organization (CRO), I have had the opportunity to hire and observe the integration of...

As a CEO, my responsibilities extend beyond profit margins and satisfying shareholders. I also find myself reflecting on the impact of my...

Dear colleagues, I wanted to share some additional information regarding the key licensed drugs for Alzheimer's disease. Specifically, I ha